- Home
- CHRS vs UFI Comparison
CHRS vs UFI Comparison
Compare CHRS & UFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- UFI
- Stock Information
- Founded
- CHRS 2010
- UFI 1969
- Country
- CHRS United States
- UFI United States
- Employees
- CHRS N/A
- UFI N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- UFI Textiles
- Sector
- CHRS Health Care
- UFI Consumer Discretionary
- Exchange
- CHRS Nasdaq
- UFI Nasdaq
- Market Cap
- CHRS 100.9M
- UFI 105.9M
- IPO Year
- CHRS 2014
- UFI N/A
- Fundamental
- Price
- CHRS $1.10
- UFI $5.59
- Analyst Decision
- CHRS Strong Buy
- UFI
- Analyst Count
- CHRS 4
- UFI 0
- Target Price
- CHRS $6.13
- UFI N/A
- AVG Volume (30 Days)
- CHRS 3.1M
- UFI 54.0K
- Earning Date
- CHRS 11-06-2024
- UFI 10-30-2024
- Dividend Yield
- CHRS N/A
- UFI N/A
- EPS Growth
- CHRS N/A
- UFI N/A
- EPS
- CHRS N/A
- UFI N/A
- Revenue
- CHRS $304,340,000.00
- UFI $590,737,000.00
- Revenue This Year
- CHRS $3.33
- UFI $11.45
- Revenue Next Year
- CHRS $16.77
- UFI $6.84
- P/E Ratio
- CHRS N/A
- UFI N/A
- Revenue Growth
- CHRS 44.19
- UFI 1.35
- 52 Week Low
- CHRS $0.66
- UFI $5.41
- 52 Week High
- CHRS $3.70
- UFI $7.91
- Technical
- Relative Strength Index (RSI)
- CHRS 69.14
- UFI 30.50
- Support Level
- CHRS $0.70
- UFI $5.50
- Resistance Level
- CHRS $0.89
- UFI $5.77
- Average True Range (ATR)
- CHRS 0.10
- UFI 0.21
- MACD
- CHRS 0.04
- UFI -0.05
- Stochastic Oscillator
- CHRS 93.70
- UFI 9.38
About CHRS Coherus BioSciences Inc.
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. The company is focused on the research, development, and commercialization of its portfolio of FDA-approved oncology products, including LOQTORZI. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company generates revenue from the United States.
About UFI Unifi Inc. New
Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.